Engflag

Calten D

Quick links to important sections

Calten D

Calten D_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calten D

Understanding Calten D

Calten D is a fixed-dose combination supplement designed to support bone health and mineral balance in the body. It integrates two primary components: calcium and vitamin D3 (cholecalciferol). These substances work together to maintain various physiological functions, particularly the structural integrity of the skeletal system.

Primary Components

  • Calcium: As the most abundant mineral in the body, calcium is essential for the formation and maintenance of bones and teeth. It also plays a critical role in nerve transmission, muscle function, and blood coagulation.
  • Vitamin D3 (Cholecalciferol): This vitamin acts as a hormone that facilitates the intestinal absorption of calcium. Without adequate vitamin D3, the body cannot effectively utilize dietary calcium, regardless of intake levels.

Purpose and Mechanism

Calten D is primarily used to address or prevent deficiencies in calcium and vitamin D. Such deficiencies can occur due to inadequate dietary intake, limited sun exposure, or physiological conditions that increase the body's requirements for these nutrients.

When these two elements are combined, the vitamin D3 component enhances the efficiency of calcium uptake in the small intestine. Once absorbed, the calcium is incorporated into the bone matrix, contributing to bone density and strength. This combination is often utilized to support long-term bone health and to manage the risk of bone density loss associated with aging.

Regulatory References

  1. MedlinePlus, Calcium Carbonate

What side effects are possible with Calten D?

Possible Side Effects and Safety Information for Calten D

Adverse Reactions

The officially documented adverse reactions associated with Calten D (a Calcium and Vitamin D combination) are predominantly related to the gastrointestinal system and potential issues from elevated calcium levels.

Classification Common Reactions
Gastrointestinal Constipation, nausea, vomiting, upset stomach, loss of appetite.

Serious and Clinically Significant Reactions:

  • Hypercalcemia (high calcium level in the blood), which can present with symptoms such as increased thirst, frequent urination, confusion, bone pain, and unusual muscle weakness.
  • Allergic reactions/Hypersensitivity, including swelling of the face, lips, tongue, or throat, or hives.
  • Renal issues, specifically the formation of kidney stones (renal calculi).

Safety Restrictions and Monitoring

This medication is contraindicated and should not be used in individuals with pre-existing conditions that affect calcium balance. These include known hypercalcemia (high calcium levels in the blood), hypercalciuria (high calcium levels in the urine), hypervitaminosis D (excess vitamin D in the body), or a history of kidney stones or tissue calcification.

Population-Specific Considerations:

  • Renal Impairment: Patients with existing kidney problems require frequent monitoring of serum calcium and phosphorus levels to prevent complications.
  • Pregnancy/Breastfeeding: Use during pregnancy or while breastfeeding requires medical consultation and strict monitoring.

Drug Interactions:

Caution is required due to potential interactions. Calten D should not be taken simultaneously with thyroid medicine. It can also interfere with the absorption of certain medications, including specific antibiotics and bisphosphonates, requiring doses to be separated by several hours.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Calten D (Calcium Carbonate and Cholecalciferol) is officially documented as resulting in conditions of Hypercalcaemia and Hypervitaminosis D. The recognized clinical manifestations listed in regulatory labeling include early symptoms such as anorexia, nausea, vomiting, and constipation, alongside fluid imbalance signs like polyuria (increased urination) and polydipsia (excessive thirst). More severe or prolonged overdose can progress to neurological changes, including headache, somnolence, and psychotic symptoms.

Documented Outcomes and Emergency Action

Regulatory documents state that severe hypercalcaemia carries a documented risk of serious systemic outcomes, primarily affecting the kidneys and heart. These complications include nephrocalcinosis, potential for acute renal failure, and the possibility of cardiac arrhythmias. Patients with pre-existing impaired renal function are noted in official labeling to be at an increased risk of toxicity.

Immediate medical attention is required if an overdose is suspected or if any symptoms of hypercalcaemia are present. The documented first procedural step is the immediate discontinuation of Calten D. Regulatory information states that no specific antidote is known. Management is supportive and typically requires continuous hospital monitoring of key laboratory parameters, including serum calcium, phosphorus, and renal function.

Therapeutic Uses of Calten D

Quick Facts

  • Therapeutic Domain 1: Management of confirmed calcium deficiency (hypocalcemia).
  • Therapeutic Domain 2: Adjunctive support for conditions related to reduced bone density, such as osteoporosis and osteomalacia.
  • Therapeutic Domain 3: Treatment of rickets in pediatric patients and other disorders related to inadequate bone mineralization.

What Calten D Treats: Main Uses and Benefits

Calten D is a medication primarily prescribed to individuals who require therapeutic management of conditions associated with low levels of calcium in the blood. This compound may support the maintenance of adequate serum calcium concentrations for essential physiological functions, including nerve and muscle support.

The medication is an available option for managing clinical calcium deficiencies (hypocalcemia) which can occur due to various underlying factors. For conditions involving reduced bone strength and integrity, such as osteoporosis and osteomalacia (softening of the bones), Calten D may be included as an adjunctive component of the patient's care plan. It is also indicated for the management of rickets, a condition affecting bone development in children, by helping to normalize processes of bone mineralization. Furthermore, Calten D may be used in the care of individuals with hypoparathyroidism, a condition characterized by low levels of parathyroid hormone, to support the regulation of calcium balance.

This therapeutic approach helps to stabilize calcium levels to support bone health across the lifespan. Patients should always review their treatment plan and potential uses of such medication with a qualified healthcare provider.

Eligibility and Restrictions for Use

Who Can and Cannot Use Calten D? — Official Regulatory Information

Official regulatory documents define strict criteria for the use of Calten D, a product containing a combination of calcium carbonate and cholecalciferol (Vitamin D3).

Populations Who Must NOT Use Calten D (Contraindications)

The medicine is formally contraindicated and must not be used by patients with:

  • Hypercalcaemia (high levels of calcium in the blood).
  • Hypercalciuria (high levels of calcium in the urine).
  • Hypervitaminosis D (high levels of Vitamin D in the body).
  • Severe Renal Impairment or Severe Renal Failure (significantly compromised kidney function).
  • Nephrolithiasis or Nephrocalcinosis (history of kidney stones or calcium deposits in the kidney).
  • Hypersensitivity or allergy to calcium carbonate, cholecalciferol (Vitamin D3), or any other component of the medicine.

Restricted or Cautious Use

Use is generally not recommended in children and adolescents under 18 years of age due to insufficient data or high-dose formulation concerns. High-dose products are also not recommended during pregnancy and lactation, though lower-dose formulations may be acceptable under medical supervision.

Patients with sarcoidosis, a tendency for kidney stone formation, or certain gastrointestinal conditions require special consideration and close medical monitoring while using this medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Pharmacokinetic Interactions

The interaction profile of Calten D is largely defined by the chelation properties of its calcium component. As a multivalent cation, Calcium Carbonate reduces the systemic absorption of several medicinal products, including Bisphosphonates, Tetracycline Antibiotics, and Quinolone Antibiotics. Regulatory labeling mandates timing separation for these agents, typically requiring administration 2 to 4 hours before or 4 to 6 hours after the Calten D dose, to mitigate this effect.

Conversely, the absorption of the fat-soluble Cholecalciferol component can be impaired by agents such as Bile Acid Sequestrants and Mineral Oil. Furthermore, official regulatory documents state that medicinal products, including certain anticonvulsants and glucocorticoids, may increase the catabolism of Vitamin D3.

Pharmacodynamic Interactions and Restrictions

Co-administration with Thiazide Diuretics carries a documented risk of hypercalcemia due to an additive effect on calcium retention. This potential for elevated serum calcium is also relevant to the increased risk of cardiac arrhythmias when taken with Cardiac Glycosides (e.g., Digoxin).

Official restrictions recommend avoiding combination with other Vitamin D Analogs due to the documented potential for toxicity. Finally, specific foods high in Oxalic Acid or Phytic Acid are noted to decrease calcium absorption, requiring at least 2 hours separation from the Calten D dose.

Mechanism of Action

The mechanism of Calten D centers on the facilitation of mineral absorption and the subsequent modulation of systemic calcium concentration. This process is driven by the synergistic actions of its two components.

Vitamin D3 (Cholecalciferol) undergoes metabolic activation in the liver and kidney before functioning as an agonist for the Vitamin D Receptor (VDR) in the small intestine. VDR activation initiates a transcriptional cascade that increases the expression of calcium-transport proteins, directly enhancing the rate of active and passive absorption of the Elemental Calcium component.

The resulting elevated serum calcium engages Calcium-Sensing Receptors (CaSRs) on the parathyroid glands. This interaction acts as a negative feedback signal that suppresses the secretion of Parathyroid Hormone (PTH). This regulatory pathway reduces the rate of bone resorption and results in the modulation of calcium concentrations. A stable supply of circulating calcium supports the integration of calcium and phosphate into the bone matrix, driving the process of skeletal mineralization, and is essential for neuromuscular signaling via stabilization of cellular electrical potentials.

Dosage and Administration Information

How to Use Calten D: Official Administration Guidelines

Calten D, a combination of Calcium Carbonate and Cholecalciferol (Vitamin D3), is administered solely via the oral route. The official administration protocol is designed to maximize the absorption of both components for continuous nutritional support.

Dosing and Frequency Patterns

The standard adult daily dose generally falls within a range intended to deliver 1000 mg to 1500 mg of elemental calcium and 400 IU to 1000 IU of Cholecalciferol (D3). This total daily amount is typically administered in a once-daily or twice-daily schedule, which helps optimize the absorption of elemental calcium. The medicine is intended for long-term use as part of a sustained mineral and bone health regimen.

Administration Conditions

Condition Instruction Rationale (Official Use Principle)
Timing Relative to Meals Must be taken with food or immediately after a meal. Enhances the solubility and absorption of Calcium Carbonate and the fat-soluble Vitamin D3.
Chewable Forms Chewable tablets must be fully chewed or dissolved in the mouth before swallowing. This ensures the proper release and absorption of the active ingredients in the digestive tract.
Missed Dose If a dose is missed, do not take a double dose; simply resume the next scheduled dose. Standard procedural rule for maintaining the prescribed daily regimen without exceeding the dose limit.

Population-Specific Use

While older adults typically receive standard adult dosing, administration to the pediatric population requires the use of lower, weight- or age-based doses of both active components. Formulations intended for adult use are often not appropriate for children.

Recent Clinical Evidence

Research evidence / Overview of studies for Calten D

This section provides an overview of the existing research involving the combination of Calcium Carbonate and Cholecalciferol (Calten D). The findings presented here describe patterns observed in studies and do not offer individual predictions or clinical recommendations.

Evidence Supporting Adjunctive Use for Bone Density and Fracture Risk

Research was conducted to explore the combination's evaluation in relation to outcomes reflecting bone structure and Bone Mineral Density (BMD). These studies were often conducted as large-scale Randomized Controlled Trials (RCTs) and subsequent comprehensive analyses of those trials. The research examined outcomes reflecting daily functioning and fracture frequency, especially in older adults, including postmenopausal women. Meta-analyses described patterns where the study group was studied in comparison to control groups regarding fracture frequency. However, findings were mixed when looking at individual RCTs.

Evidence for Management of Clinical Calcium Deficiency (Hypocalcemia)

The combination product was evaluated in studies focusing on outcomes related to mineral or physiological imbalance, specifically the management of clinical deficiency, known as hypocalcemia. Studies monitored measurable shifts toward the target calcium ranges in the blood and tracked the response of hormones like Parathyroid Hormone (PTH). Comparative evidence is lacking for long-term patient outcomes versus other calcium forms, and data for certain groups of patients with complex causes remain insufficient for detailed conclusions.

Evidence in the Treatment of Rickets and Osteomalacia

Research examined the combination product's use in conditions associated with acute or disruptive episodes of bone malformation, specifically Rickets in children and Osteomalacia in adults. Findings describe patterns observed in the studies where administering the required nutrients was observed during periods with signs of changing skeletal structure. Radiological reports also described changes in the skeletal structure that were consistent with the physiological adjustments monitored in Rickets-related studies.

What Remains Uncertain About Calten D Research

The final section synthesizes the key evidence gaps, which include areas of mixed findings across major studies. Furthermore, there is limited information for long-term outcomes, and the comparative evidence is lacking when assessing this combination against single-nutrient alternatives. Research is ongoing to provide a clearer understanding of these complex outcomes.

Key Studies & References

  1. Calcium Carbonate: MedlinePlus Drug Information
  2. Hypocalcemia in Chronic Kidney Disease: Causes, Consequences, and Management

Frequently Asked Questions (FAQ)

Common questions about Calten D (FAQ)

Q: Can I drive or operate machinery after taking this supplement?

Official product information notes that high calcium levels in the blood, a condition called hypercalcemia, can be a side effect. Symptoms associated with this condition may include drowsiness and muscle weakness. Patients who experience these symptoms are encouraged to consider their ability to perform tasks requiring full concentration, and any concerns related to these effects should be reviewed with a healthcare provider.

Q: Are there any known interactions with Ibuprofen (Advil, Motrin)?

Regulatory drug interaction reports typically do not indicate a direct interaction between the active ingredients in Calten D and common non-steroidal anti-inflammatory drugs (NSAIDs) like Ibuprofen. However, regulatory documents state that patients are typically instructed to share a full list of all medications they are taking, including NSAIDs, with their healthcare provider. This is done to ensure the management is aligned with the individual's specific health profile.

Q: Can I drink alcohol while taking Calcium and Vitamin D3?

Official labels state that consumption of excessive alcohol is noted to potentially impact the body's ability to use the nutrients effectively. Information regarding alcohol use is intended to be reviewed with a healthcare provider. The official product information specifies that any concerns should be addressed with a medical professional.

Q: How long is the shelf life, and when does the medication expire?

According to the official product information, the shelf life for Calten D is typically 24 months from the date it was manufactured. For storage, regulatory documents state the product should be kept in a dry place, below a specific temperature (often 25 C or 30 C), and protected from light. The specific expiry date is printed on the product packaging.

How should Calten D be stored and disposed of?

How to Store and Dispose of Calten D?

The storage and disposal of Calten D (Calcium Carbonate and Cholecalciferol) must follow specific regulatory requirements to maintain product integrity and ensure safety.

Official Storage Conditions

Requirement Specific Instruction
Temperature Store at controlled room temperature (e.g., 20 C to 25 C). Do not freeze or store above 30 C.
Protection Keep the product in a dry place and protect from light and moisture.
Container Keep the container tightly closed and store the medicine in its original package.
Safety Store Calten D out of the sight and reach of children.

Disposal Requirements

Expired or unused Calten D must not be disposed of by flushing down a toilet or sink or placing in household trash. To prevent environmental contamination, disposal must adhere to local regulations for pharmaceutical waste, often requiring use of a medicine take-back program or consultation with a pharmacist.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Calten D found in:

A-Z Index: